News
A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience the cardiovascular benefits associated with the drug.
A cheap over-the-counter supplement could hold the key to preventing heart failure in people with Type 2 diabetes, according ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Welltica+ on MSN11h
Experts Warn: This Medication Could Lead to BlindnessThe researchers discovered that after just six months of use, patients had double the risk of developing neovascular ...
A newly published randomized controlled trial in Frontiers in Medicine has found that the practice of Transcendental ...
Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...
Apple cider vinegar can cause side effects when taking it and certain medications. Learn which medications apple cider ...
In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...
1d
Dagens.com on MSNDiabetes Drug Shows Promise for Heart Protection in Cancer PatientsA widely used diabetes medication could significantly boost recovery for cancer patients by reducing the risk of heart ...
It is important to note that Ozempic and blindness are not usually connected, and vision loss is not a commonly reported or an expected side effect of this weight loss drug. However, if you are on ...
Are you tired of boring dieting and gruesome workouts? Then, medical weight loss treatment can be a solution for you. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results